Metraipolis › archive › dc_c44440cac5df

FibroAgent: An Agentic AI Tool for Liver Fibrosis Screening and Clinical Decision Support in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Europe PMC PMID:42083670

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42083670
DOI
10.7759/cureus.106372
License (as archived)
solo-consultazione
Archived
2026-10-08T03:25:49.304Z
SHA-256 of the archived text
1460e7e9a32912e42fdbe0e5d1145a32bd57fa9ea55290a84b11803ba92bfd88
Stable URL of this page
https://metraipolis.com/documento/dc_c44440cac5df

How to cite

FibroAgent: An Agentic AI Tool for Liver Fibrosis Screening and Clinical Decision Support in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Europe PMC PMID:42083670 — Europe PMC (en), https://europepmc.org/article/MED/42083670 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c44440cac5df (Metraipolis archive dc_c44440cac5df, sha256 1460e7e9a32912e42fdbe0e5d1145a32bd57fa9ea55290a84b11803ba92bfd88)
BibTeX
@misc{dcc44440cac5df,
  title = {FibroAgent: An Agentic AI Tool for Liver Fibrosis Screening and Clinical Decision Support in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Europe PMC PMID:42083670},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42083670},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c44440cac5df; sha256 1460e7e9a32912e42fdbe0e5d1145a32bd57fa9ea55290a84b11803ba92bfd88},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42083670. Agents can read the archived copy with the MCP tool read_document.